A Specific Chemical Difference Between the Globins of Normal Human and Sickle-Cell Anæmia Hæmoglobin
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sickle cell anemia is caused by homozygosity of the beta-S (βS) allele (located on chromosome 11p15.5), which differs from the wild-type β-allele by a single nucleotide polymorphism dbSNP Rs334(T;T) in which GTG is substituted for GAG in the sixth codon of the β-globin gene (1, 3, 5, 6).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [5]
Citations
Cites
Sickle Cell Anemia, a Molecular Disease
Pauling, L., Itano, H. A., Singer, S. J., & Wells, I. C. (1949) · Science · doi:10.1126/science.110.2865.543 · Cited by 2,319
The free amino groups of haemoglobins
Porter, R., & Sanger, F. (1948) · Biochemical Journal · doi:10.1042/bj0420287 · Cited by 382
The Inheritance of Sickle Cell Anemia
Neel, J. V. (1949) · Science · doi:10.1126/science.110.2846.64 · Cited by 360
�ber Papierionophorese bei Spannungsgef�llen von 50 Volt/cm
Michl, H. (1951) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/bf00900846 · Cited by 253
State of Hæmoglobin in Sickle-Cell Anæmia
PERUTZ, M. F., & MITCHISON, J. M. (1950) · Nature · doi:10.1038/166677a0 · Cited by 221
X-Ray and Solubility Studies of the Hæmoglobin of Sickle-Cell Anæmia Patients
PERUTZ, M. F., LIQUORI, A. M., & EIRICH, F. (1951) · Nature · doi:10.1038/167929a0 · Cited by 187
Sulphydryl groups in haemoglobins
Ingram, V. M. (1955) · Biochemical Journal · doi:10.1042/bj0590653 · Cited by 94
Self-citationAMINO ACID COMPOSITION OF HEMOGLOBINS OF NORMAL NEGROES AND SICKLE-CELL ANEMICS
Schroeder, W. A., Kay, L. M., Wells, I. C., Gerke, C., & Moss, J. (1950) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50947-4 · Cited by 67
Amino-Acid Composition of Four Different Kinds of Human Hæmoglobin
Huisman, T. H. J., Jonxis, J. H. P., & Schaaf, P. (1955) · Nature · doi:10.1038/175902a0 · Cited by 34
The sulfhydryl groups of four different human haemoglobins
Hommes, F. A., Santema-Drinkwaard, J., & Huisman, T. H. J. (1956) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(56)90358-4 · Cited by 25
Cited by
Genetic Mapping in Human Disease
Altshuler, D., Daly, M. J., & Lander, E. S. (2008) · Science · doi:10.1126/science.1156409 · Cited by 1,452
Garen, A., & Levinthal, C. (1960) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(60)91282-8 · Cited by 1,400
Electrostatic Interactions in Protein Structure, Folding, Binding, and Condensation
Zhou, H.-X., & Pang, X. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00305 · Cited by 1,190
INGRAM, V. M. (1957) · Nature · doi:10.1038/180326a0 · Cited by 978
Self-citationEnhanced prime editing systems by manipulating cellular determinants of editing outcomes
Chen, P. J., Hussmann, J. A., Yan, J., Knipping, F., Ravisankar, P., Chen, P.-F., Chen, C., Nelson, J. W., Newby, G. A., Sahin, M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.09.018 · Cited by 809
“First, wemade a silent G,C-to-A,T transversion at the 6 codon ofHBB, which ismutated in sickle cell disease patients (Ingram, 1956).”
BackgroundMethodInfluentialPathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Peptide Separation by Two-dimensional Chromatography and Electrophoresis
Katz, A. M., Dreyer, W. J., & Anfinsen, C. B. (1959) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69690-5 · Cited by 726
Gene therapy in a patient with sickle cell disease
Ribeil, J.-A., Hacein-Bey-Abina, S., Payen, E., Magnani, A., Semeraro, M., Magrin, E., Caccavelli, L., Neven, B., Bourget, P., El Nemer, W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1609677 · Cited by 696
THE QTN PROGRAM AND THE ALLELES THAT MATTER FOR EVOLUTION: ALL THAT'S GOLD DOES NOT GLITTER
Rockman, M. V. (2012) · Evolution · doi:10.1111/j.1558-5646.2011.01486.x · Cited by 670
DEOXYRIBONUCLEIC ACID-DIRECTED SYNTHESIS OF RIBONUCLEIC ACID BY AN ENZYME FROM ESCHERICHIA COLI
Chamberlin, M., & Berg, P. (1962) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.48.1.81 · Cited by 627
Ingram, V. M. (1989) · PubMed · Cited by 626
Self-citationSickle Cell Hemoglobin Polymerization
Eaton, W. A., & Hofrichter, J. (1990) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60287-9 · Cited by 623
Shape and Biomechanical Characteristics of Human Red Blood Cells in Health and Disease
Diez-Silva, M., Dao, M., Han, J., Lim, C.-T., & Suresh, S. (2010) · MRS Bulletin · doi:10.1557/mrs2010.571 · Cited by 595
Ingram, V. M. (1958) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(58)90516-x · Cited by 545
Self-citationTransgenic Knockout Mice with Exclusively Human Sickle Hemoglobin and Sickle Cell Disease
Pászty, C., Brion, C. M., Manci, E., Witkowska, H. E., Stevens, M. E., Mohandas, N., & Rubin, E. M. (1997) · Science · doi:10.1126/science.278.5339.876 · Cited by 467
Sickle cell pain: a critical reappraisal
Ballas, S. K., Gupta, K., & Adams-Graves, P. (2012) · Blood · doi:10.1182/blood-2012-04-383430 · Cited by 445
A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin Disorders
Perrine, S. P., Ginder, G. D., Faller, D. V., Dover, G. H., Ikuta, T., Witkowska, H. E., Cai, S.-P., Vichinsky, E. P., & Olivieri, N. F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280202 · Cited by 437
Dipple, K. M., & McCabe, E. R. B. (2000) · The American Journal of Human Genetics · doi:10.1086/302938 · Cited by 418
“Sickle-cell disease is the prototypical hemoglobinopathy, with hemoglobin S the initial hemoglobin variant to be described (Pauling et al. 1949) and to have its amino acid mutation reported (Ingram 1956).”
BackgroundHill, R. L. (1965) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60388-5 · Cited by 411
THE MUTATION AND POLYMORPHISM OF THE HUMAN β-GLOBIN GENE AND ITS SURROUNDING DNA
Orkin, S. H., & Kazazian, H. H. (1984) · Annual Review of Genetics · doi:10.1146/annurev.ge.18.120184.001023 · Cited by 395
Hemoglobin research and the origins of molecular medicine
Schechter, A. N. (2008) · Blood · doi:10.1182/blood-2008-04-078188 · Cited by 381
Correction of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing
Xu, J., Peng, C., Sankaran, V. G., Shao, Z., Esrick, E. B., Chong, B. G., Ippolito, G. C., Fujiwara, Y., Ebert, B. L., Tucker, P. W., et al. (2011) · Science · doi:10.1126/science.1211053 · Cited by 326
Correction of sickle cell disease by homologous recombination in embryonic stem cells
Wu, L.-C., Sun, C.-W., Ryan, T. M., Pawlik, K. M., Ren, J., & Townes, T. M. (2006) · Blood · doi:10.1182/blood-2006-02-004812 · Cited by 327
Biological atomic force microscopy: what is achieved and what is needed
Shao, Z., Mou, J., Czajkowsky, D. M., Yang, J., & Yuan, J.-Y. (1996) · Advances in Physics · doi:10.1080/00018739600101467 · Cited by 325
Barabino, G. A., Platt, M. O., & Kaul, D. K. (2010) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-070909-105339 · Cited by 311
Knockout-Transgenic Mouse Model of Sickle Cell Disease
Ryan, T. M., Ciavatta, D. J., & Townes, T. M. (1997) · Science · doi:10.1126/science.278.5339.873 · Cited by 300
Steinberg, M. H. (2008) · The Scientific World JOURNAL · doi:10.1100/tsw.2008.157 · Cited by 293
Bioinformatics and Drug Discovery
Xia, X. (2017) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026617666161116143440 · Cited by 252
“Another example of activating alternative biological pathways or genes with partial functional redundancy involves sickle-cell anemia [33] caused by a single amino acid replacement in human beta-globin gene [34, 35].”
BackgroundSustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease.
Atweh, G. F., Sutton, M., Nassif, I. I., Boosalis, V., Dover, G. J., Wallenstein, S. R., Wright, E. C., McMahon, L. C., Stamatoyannopoulos, G., Faller, D. V., et al. (1999) · PubMed · doi:10.1182/blood.v93.6.1790.406k27_1790_1797 · Cited by 253
Yates, C. M., & Sternberg, M. J. E. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.07.012 · Cited by 238
Sickle cell disease: a neglected chronic disease of increasing global health importance
Chakravorty, S., & Williams, T. N. (2015) · Archives of Disease in Childhood · doi:10.1136/archdischild-2013-303773 · Cited by 236
Sickle-Cell Anemia: Molecular and Cellular Bases of Therapeutic Approaches: (First of Three Parts)
Dean, J., & Schechter, A. N. (1978) · New England Journal of Medicine · doi:10.1056/nejm197810052991405 · Cited by 237
Structure and Biological Activity of Immunoglobulins
Cohen, S., & Porter, R. R. (1964) · Advances in Immunology · doi:10.1016/s0065-2776(08)60710-5 · Cited by 234
Abnormal human haemoglobins. III the chemical difference between normal and sickle cell haemoglobins
Ingram, V. M. (1959) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(59)90183-0 · Cited by 227
Self-citationThe intracellular polymerization of sickle hemoglobin and its relevance to sickle cell disease
Noguchi, C., & Schechter, A. (1981) · Blood · doi:10.1182/blood.v58.6.1057.1057 · Cited by 220
Genetic Basis of the Thalassæmia Diseases
INGRAM, V. M., & STRETTON, A. O. W. (1959) · Nature · doi:10.1038/1841903a0 · Cited by 217
Self-citationAntonarakis, S. E., Boehm, C. D., Serjeant, G. R., Theisen, C. E., Dover, G. J., & Kazazian, H. H. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.3.853 · Cited by 217
The genetic epidemiology of cannabis use, abuse and dependence
Agrawal, A., & Lynskey, M. T. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01399.x · Cited by 214
Structural Reduction in Evolution
Brace, C. L. (1963) · The American Naturalist · doi:10.1086/282252 · Cited by 211
“Furthermore, the simplest form of modification of the basic genetic material accounts for single unit (amino acid) modifications in the corresponding protein (Ingram, 1956, 1957, 1959; Lehmann and Ager, 1960).”
BackgroundMast cell activation contributes to sickle cell pathobiology and pain in mice
Vincent, L., Vang, D., Nguyen, J., Gupta, M., Luk, K., Ericson, M. E., Simone, D. A., & Gupta, K. (2013) · Blood · doi:10.1182/blood-2013-04-498105 · Cited by 209
SICKLE CELL ANAEMIA AND MALARIA
Luzzatto, L. (2012) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2012.065 · Cited by 205
The emerging understanding of sickle cell disease
Serjeant, G. R. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02557.x · Cited by 203
“This method enabled the separation of constituent peptides and demonstrated that a peptide in HbS was more positively charged than in HbA (Ingram, 1956).”
MethodInfluentialTHE HISTONES OF CHICKEN ERYTHROCYTE NUCLEI
Neelin, J. M., Callahan, P. X., Lamb, D. C., & Murray, K. (1964) · Canadian Journal of Biochemistry · doi:10.1139/o64-185 · Cited by 191
Levasseur, D. N., Ryan, T. M., Pawlik, K. M., & Townes, T. M. (2003) · Blood · doi:10.1182/blood-2003-04-1251 · Cited by 195
Detrimental effects of adenosine signaling in sickle cell disease
Zhang, Y., Dai, Y., Wen, J., Zhang, W., Grenz, A., Sun, H., Tao, L., Lu, G., Alexander, D. C., Milburn, M. V., et al. (2011) · Nature Medicine · doi:10.1038/nm.2280 · Cited by 193
“2280" language="eng" relation="no"> SCD is a devastating inherited hemolytic disorder that affects red blood cells (RBCs) and is caused by a point mutation that results in the substitution of valine for glutamic acid at the sixth position of the β-globin chain of hemoglobi”
BackgroundViral Vectors in Gene Therapy: Where Do We Stand in 2023?
Lundstrom, K. (2023) · Viruses · doi:10.3390/v15030698 · Cited by 187
“In the context of sickle cell disease (SCD), which is caused by a single mutation in the β‐ globin chain of the adult α 2 β 2 hemoglobin tetramer [213], HSCs transduced with LV vectors expressing a β A ‐ globin variant have demonstrated long ‐ term expression for 10 months and accumulation of anti…”
Chaturvedi, S., & DeBaun, M. R. (2016) · American Journal of Hematology · doi:10.1002/ajh.24235 · Cited by 186
“Soon after, a combination of electrophoresis and chromatography identified an abnormal peptide that resulted from the substitution of valine for glutamic acid at position 6 of the beta globin chain [10,11].”
BackgroundSoluble Guanylate Cyclase Stimulators and Activators
Sandner, P., Zimmer, D. P., Milne, G. T., Follmann, M., Hobbs, A., & Stasch, J.-P. (2018) · Handbook of Experimental Pharmacology · doi:10.1007/164_2018_197 · Cited by 180
“Sickle cell disease (SCD) is an inherited blood disorder resulting from an allele of the hemoglobin beta gene that results in sickling of red blood cells (Ingram 1956).”
BackgroundIon Transport Pathology in the Mechanism of Sickle Cell Dehydration
Lew, V. L., & Bookchin, R. M. (2005) · Physiological Reviews · doi:10.1152/physrev.00052.2003 · Cited by 173
“In one of the first applications of two-dimensional peptide mapping, Ingram (145, 146) identified the precise molecular difference between Hbs A and S as a single amino acid substitution on the -chain of Hb, valine for glutamic acid in position 6.”
BackgroundTHE ELECTROPHORETIC PATTERNS OF AVIAN EGG‐WHITE PROTEINS AS TAXONOMIC CHARACTERS*
SIBLEY, C. G. (1960) · Ibis · doi:10.1111/j.1474-919x.1960.tb07114.x · Cited by 173
The high resolution crystal structure of deoxyhemoglobin S
Harrington, D. J., Adachi, K., & Royer, W. E. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1253 · Cited by 171
BIOSYNTHESIS OF THE COAT PROTEIN OF COLIPHAGE f2 BY E. COLI EXTRACTS
Nathans, D., Notani, G., Schwartz, J. H., & Zinder, N. D. (1962) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.48.8.1424 · Cited by 170
THE TRYPTOPHAN SYNTHETASE SYSTEM
Yanofsky, C. (1960) · Bacteriological Reviews · doi:10.1128/br.24.2.221-245.1960 · Cited by 219
Further Studies on the Site Phosphorylated in the Phosphorylase b to a Reaction*
Nolan, C., Novoa, W. B., Krebs, E. G., & Fischer, E. H. (1964) · Biochemistry · doi:10.1021/bi00892a013 · Cited by 168
B ALANCED P OLYMORPHISM S ELECTED BY G ENETIC V ERSUS I NFECTIOUS H UMAN D ISEASE
Dean, M., Carrington, M., & O'Brien, S. J. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.022502.103149 · Cited by 167
The Watson-Crick Model and Reductionism
SCHAFFNER, K. F. (1969) · The British Journal for the Philosophy of Science · doi:10.1093/bjps/20.4.325 · Cited by 165
Huehns, E. R., & Shooter, E. M. (1965) · Journal of Medical Genetics · doi:10.1136/jmg.2.1.48 · Cited by 163
Erythropoiesis: insights into pathophysiology and treatments in 2017
Zivot, A., Lipton, J. M., Narla, A., & Blanc, L. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0011-z · Cited by 163
Sickle Cell Anaemia: Progress in Pathogenesis and Treatment
Ballas, S. K. (2002) · Drugs · doi:10.2165/00003495-200262080-00003 · Cited by 181
“This change, in turn, results in replacement of the normal glutamic acid with valine at position 6 of the β-globin chain and the formation of sickle Hb.[6,7] In a sense, the mutation is akin to a typographical Table I. Beneficial effects of hydroxyurea in patients with sickle cell anaemia Decreases the frequency of ac…”
BRAUNITZER†, G., Hilse, K., RUDLOFF, V., & HILSCHMANN, N. (1964) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60188-6 · Cited by 152
The Human Hemoglobins: Their Properties and Genetic Control
Itano, H. A. (1957) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60117-5 · Cited by 151
Park, S. H., Lee, C. M., Dever, D. P., Davis, T., Camarena, J., Srifa, W., Zhang, Y., Paikari, A., Chang, A. K., Porteus, M. H., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz475 · Cited by 163
The acid extraction of histones from calf thymus deoxyribonucleoprotein
Murray, K. (1966) · Journal of Molecular Biology · doi:10.1016/s0022-2836(66)80116-x · Cited by 142
Sickle‐cell haemoglobin polymerization: is it the primary pathogenic event of sickle‐cell anaemia?
Vekilov, P. G. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06794.x · Cited by 137
“Thus, in Galkin & Vekilov (2004) HbS nucleation rate data were interpreted via a one-step mechanisms and the nucleus sizes were determined using the nucleation theorem for such one-step nucleation (Oxtoby & Kashchiev, 1994; Kashchiev, 2000).”
MethodHuman Sickle Hemoglobin in Transgenic Mice
Ryan, T. M., Townes, T. M., Reilly, M. P., Asakura, T., Palmiter, R. D., Brinster, R. L., & Behringer, R. R. (1990) · Science · doi:10.1126/science.2154033 · Cited by 130
Amankwa, L. N., & Kuhr, W. G. (1992) · Analytical Chemistry · doi:10.1021/ac00038a019 · Cited by 131
McKusick, V. A. (1991) · Nature · doi:10.1038/352279a0 · Cited by 128
An oligonucleotide mapping procedure and its use in the study of tobacco mosaic virus nucleic acid
Rushizky, G. W., & Knight, C. A. (1960) · Virology · doi:10.1016/0042-6822(60)90064-7 · Cited by 126
Inborn errors of metabolism: the flux from Mendelian to complex diseases
Lanpher, B. C., Brunetti‐Pierri, N., & Lee, B. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1880 · Cited by 130
Synthesis of Functional Human Hemoglobin in Transgenic Mice
Behringer, R. R., Ryan, T. M., Reilly, M. P., Asakura, T., Palmiter, R. D., Brinster, R. L., & Townes, T. M. (1989) · Science · doi:10.1126/science.2772649 · Cited by 127
The histidine residue in the active centre of ribonuclease
Barnard, E. A., & Stein, W. D. (1959) · Journal of Molecular Biology · doi:10.1016/s0022-2836(59)80016-4 · Cited by 123
Beddell, C. R., Goodford, P. J., Kneen, G., White, R. D., Wilkinson, S., & Wootton, R. (1984) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1984.tb10775.x · Cited by 121
Metastable Mesoscopic Clusters in Solutions of Sickle-Cell Hemoglobin
Pan, W., Galkin, O., Filobelo, L. F., Nagel, R. L., & Vekilov, P. G. (2006) · Biophysical Journal · doi:10.1529/biophysj.106.094854 · Cited by 120
“Hence (49) g2ðtÞ 1 1⁄4 A1e t=t1 1 A2e t=t2 2 1 eð0;sðtÞÞ; (2)”
Gene therapy for sickle cell disease: An update
Demirci, S., Uchida, N., & Tisdale, J. F. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2018.04.003 · Cited by 165
Two-Step Mechanism of Homogeneous Nucleation of Sickle Cell Hemoglobin Polymers
Galkin, O., Pan, W., Filobelo, L. F., Hirsch, R. E., Nagel, R. L., & Vekilov, P. G. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.103705 · Cited by 115
“The charge difference was attributed to a mutation from glutamate to valine ( 5 ) at the sixth site of the two b-chains of hemoglobin.”
BackgroundMankad, V. N., Williams, J. P., Harpen, M. D., Manci, E. A., Longenecker, G. L., Moore, R., Shah, A. K., Ym, Y., & Brogdon, B. (1990) · Blood · doi:10.1182/blood.v75.1.274.274 · Cited by 114
Malaria continues to select for sickle cell trait in Central Africa
Elguero, E., Délicat-Loembet, L. M., Rougeron, V., Arnathau, C., Roche, B., Becquart, P., Gonzalez, J.-P., Nkoghe, D., Sica, L., Leroy, E. M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505665112 · Cited by 111
The First Sequence: Fred Sanger and Insulin
Stretton, A. O. W. (2002) · Genetics · doi:10.1093/genetics/162.2.527 · Cited by 111
Allelomorphism and the Chemical Differences of the Human Hæmoglobins A, S and C
Hunt, J. A., & Ingram, V. M. (1958) · Nature · doi:10.1038/1811062a0 · Cited by 108
Self-citationRole of the Biomolecular Energy Gap in Protein Design, Structure, and Evolution
Fleishman, S. J., & Baker, D. A. (2012) · Cell · doi:10.1016/j.cell.2012.03.016 · Cited by 111
Soussi, T., & Béroud, C. (2003) · Human Mutation · doi:10.1002/humu.10189 · Cited by 103
“Using protein sequencing, Vernon Ingram was the first to discover that a small change in the hemoglobin protein could lead to human sickle-cell anemia [Ingram, 1956].”
MethodA transgenic mouse model of sickle cell disorder
Greaves, D. R., Fraser, P., Vidal, M., Hedges, M., Ropers, D., Luzzatto, L., & Grosveld, F. G. (1990) · Nature · doi:10.1038/343183a0 · Cited by 113
One hundred years of sickle cell disease
Serjeant, G. R. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08419.x · Cited by 112
“A combination of electrophoresis and chromatography (fingerprinting) identified an abnormal peptide (Ingram, 1956) which was later shown to result from the substitution of valine for glutamic acid at position 6 from the amino terminus of the beta chain (Hunt & Ingram, 1958).”
BackgroundSingh, A., Irfan, H., Fatima, E., Nazir, Z., Verma, A., & Akilimali, A. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002146 · Cited by 145
Hemoglobin Freiburg: Abnormal Hemoglobin Due to Deletion of a Single Amino Acid Residue
Jones, R. T., Brimhall, B., Huisman, T. H. J., Kleihauer, E., & Betke, K. (1966) · Science · doi:10.1126/science.154.3752.1024 · Cited by 100
Characterization of a Chemical Abnormality in Hemoglobin G
Hill, R. L., Swenson, R. T., & Schwartz, H. C. (1960) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)81333-7 · Cited by 99
Splenic Complications of Sickle Cell Anemia and the Role of Splenectomy
Al-Salem, A. H. (2010) · ISRN Hematology · doi:10.5402/2011/864257 · Cited by 100
The Biophysics of Sickle Cell Hydroxyurea Therapy
Eaton, W. A., & Hofrichter, J. (1995) · Science · doi:10.1126/science.7539154 · Cited by 96
Targeting novel mechanisms of pain in sickle cell disease
Tran, H., Gupta, M., & Gupta, K. (2017) · Blood · doi:10.1182/blood-2017-05-782003 · Cited by 102
“SCD is an autosomal recessive disorder caused by substitution of a valine residue for glutamic acid at position 6 in β-globin, resulting in sickle hemoglobin (HbS).(4) A unique feature of SCD is”
BackgroundMechanisms of Homogeneous Nucleation of Polymers of Sickle Cell Anemia Hemoglobin in Deoxy State
Galkin, O., & Vekilov, P. G. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.12.019 · Cited by 95
Normal and Abnormal Human Hemoglobins
Huisman, T. H. J. (1963) · Advances in clinical chemistry · doi:10.1016/s0065-2423(08)60240-1 · Cited by 94
Structural divergence and distant relationships in proteins: evolution of the globins
Lecomte, J. T. J., Vuletich, D. A., & Lesk, A. M. (2005) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2005.05.008 · Cited by 92
[22] Two-dimensional thin-layer methods
Gracy, R. W. (1977) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(77)47024-1 · Cited by 91
GENITOURINARY COMPLICATIONS OF SICKLE CELL DISEASE
BRUNO, D., Wigfall, D. R., Zimmerman, S. A., Rosoff, P. M., & Wiener, J. S. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)65841-7 · Cited by 88
Ormsby, R. J., Ranganathan, S., Tong, J. C., Griggs, K. M., Dimasi, D. P., Hewitt, A. W., Burdon, K. P., Craig, J. E., Hoh, J., & Gordon, D. L. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1297 · Cited by 87
“One example is a polymorphism in the -globin gene, which protects against malarial parasite infection but causes sickle cell anemia.(70) The observation that FH and FHL-1 Y402H variant have significantly reduced binding to GAS M6 protein supports this hypothesis.”
BackgroundMutations in the noncoding genome
Scacheri, C. A., & Scacheri, P. C. (2015) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000283 · Cited by 83
The DNA methylation machinery as a target for anticancer therapy
Szyf, M. (1996) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(96)00002-2 · Cited by 98
Human chromosome 11 DNA sequence and analysis including novel gene identification
Taylor, T. D., Noguchi, H., Totoki, Y., Toyoda, A., Kuroki, Y., Dewar, K., Lloyd, C., Itoh, T., Takeda, T., Kim, D. W., et al. (2006) · Nature · doi:10.1038/nature04632 · Cited by 83
“(4) Non-olfactory receptor pseudogenes.”
Thalassaemia: the long road from bedside to genome
Weatherall, D. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1406 · Cited by 79
On the microheterogeneity of horse myoglobin
Åkeson, Å., & Theorell, H. (1960) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(60)90507-5 · Cited by 81
Metadata
- Authors
- INGRAM, V. M.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- INGRAM, V. M.
- Venue
- Nature
- Published
- 1956-10
- Volume
- 178
- Issue
- 4537
- Pages
- 792-794
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2089819802
- Cited by
- 896
- References
- 12
- Citations by year
- 2026: 21 · 2025: 23 · 2024: 24 · 2023: 26 · 2022: 41 · 2021: 22 · 2020: 17 · 2019: 31 · 2018: 37 · 2017: 25 · 2016: 30 · 2015: 19 · 2014: 25 · 2013: 26 · 2012: 17
- FWCI
- 29.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- globin, sickle cell disease, hemoglobin, hemoglobin structure, hemoglobinopathies
- MeSH terms
- Anemia, Anemia, Sickle Cell, Globins, Hemoglobins, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.